{"text": ["Here's", "Why", "Voyager", "Therapeutics", "Stock", "Rose", "as", "Much", "as", "13%", "Today"], "created_at": "2019-03-04 23:08:25"}
{"text": ["Here's", "Why", "Voyager", "Therapeutics", "Stock", "Rose", "as", "Much", "as", "13%", "Today"], "created_at": "2019-03-04 23:08:25"}
{"text": ["Top", "Research", "Reports", "for", "Intel,", "AbbVie", "&", "United", "Technologies"], "created_at": "2019-03-04 20:27:08"}
{"text": ["AbbVie", "Gets", "CHMP", "Nod", "for", "Psoriasis", "Candidate", "Risankizumab"], "created_at": "2019-03-04 17:12:01"}
{"text": ["AbbVie", "Gets", "CHMP", "Nod", "for", "Psoriasis", "Candidate", "Risankizumab"], "created_at": "2019-03-04 17:12:01"}
{"text": ["AbbVie", "Gets", "CHMP", "Nod", "for", "Psoriasis", "Candidate", "Risankizumab"], "created_at": "2019-03-04 15:05:03"}
{"text": ["This", "Is", "Why", "TG", "Therapeutics", "Stock", "Soared", "65.9%", "in", "February"], "created_at": "2019-03-04 14:15:24"}
{"text": ["This", "Is", "Why", "TG", "Therapeutics", "Stock", "Soared", "65.9%", "in", "February"], "created_at": "2019-03-04 14:15:24"}
